Stock Events

Stock Events

YiChang HEC ChangJiang Pharmaceutical 

$0.55
2
+$0+0% Friday 20:00

Statistics

Day High
0.55
Day Low
0.55
52W High
0.55
52W Low
0.55
Volume
25,000
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
34.74%
Dividend
0.19

Upcoming

4
AUG
Dividend Ex
Estimated
 
30
OCT
Dividend Payment
Estimated
 
4
AUG 27
Dividend Ex
Estimated
 
29
OCT 27
Dividend Payment
Estimated
 

Dividends

34.74%Dividend Yield
Oct 25
$0.19
Nov 20
$0.01
Jul 20
$0.02
Nov 19
$0.07
Jul 19
$0.04
10Y Growth
32.56%
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

22AugExpected
Q4 2023
Q2 2024
Q4 2024
Q2 2025
0.11
0.44
0.77
1.11
Expected EPS
N/A
Actual EPS
N/A

Financials

13%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
511.74MRevenue
66.55MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow YIHCF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zai Lab Limited
ZLAB
Mkt Cap2.91B
Zai Lab Limited is a Shanghai-based innovative biopharmaceutical company that develops and commercializes therapies in oncology and autoimmune diseases, overlapping with YiChang HEC's focus areas.
HUTCHMED (China) Limited
HCM
Mkt Cap2.52B
Hutchison China MediTech Limited, known as Chi-Med, is a biopharmaceutical company that develops therapies for oncology and immunological diseases, competing in similar markets as YiChang HEC.
Sinovac Biotech
SVA
Mkt Cap642.44M
Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases, competing in the broader pharmaceutical field.
Can-Fite Biopharma
CANF
Mkt Cap15.35M
Can-Fite BioPharma Ltd. is an advanced clinical stage drug development company with several drugs in the pipeline that could compete with YiChang HEC's products.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline plc, a leading global pharmaceutical company, has a strong presence in China and competes across various therapeutic areas including those targeted by YiChang HEC.
Novartis
NVS
Mkt Cap237.61B
Novartis AG is a global healthcare company based in Switzerland that operates in similar therapeutic areas as YiChang HEC, making it a direct competitor in the global market.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. is one of the world's largest pharmaceutical companies, with a significant presence in China and competing across various drug categories, including those pursued by YiChang HEC.

About

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, and cardiovascular diseases in the People's Republic of China. It also manufactures and sells active pharmaceutical ingredients; researches and develops medical devices and drugs, as well as biotechnology; and provides medical consulting services. The company sells its products to hospitals and medical institutions through a network of distributors. It has a strategic cooperation framework agreement with Alibaba Health Technology (China) Limited to carry out influenza special projects; Jointown Pharmaceutical Group Co., Ltd.; Guangdong Yihao Pharmaceutical Co., Ltd.; and Shenzhen HEC Industrial Development Co., Ltd, as well as strategic cooperative partnership with China National Accord Medicines Corporation Ltd. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. The company was incorporated in 2001 and is based in Yichang, China. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a subsidiary of Guangdong HEC Technology Holding Co., Ltd.
Show more...
CEO
Mr. Juncai Jiang
Employees
4618
Country
US
ISIN
CNE1000023R6

Listings

OTC Link
US
YIHCF

0 Comments

Share your thoughts

FAQ

What is YiChang HEC ChangJiang Pharmaceutical stock price today?▼
The current price of YIHCF is $0.55 USD — it has increased by +0% in the past 24 hours. Watch YiChang HEC ChangJiang Pharmaceutical stock price performance more closely on the chart.
What is YiChang HEC ChangJiang Pharmaceutical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange YiChang HEC ChangJiang Pharmaceutical stocks are traded under the ticker YIHCF.
What is YiChang HEC ChangJiang Pharmaceutical revenue for the last year?▼
YiChang HEC ChangJiang Pharmaceutical revenue for the last year amounts to 511.74M USD.
What is YiChang HEC ChangJiang Pharmaceutical net income for the last year?▼
YIHCF net income for the last year is 66.55M USD.
Does YiChang HEC ChangJiang Pharmaceutical pay dividends?▼
Yes, YIHCF dividends are paid annual. The last dividend per share was 0.19 USD. As of today, Dividend Yield (FWD)% is 34.74%.
How many employees does YiChang HEC ChangJiang Pharmaceutical have?▼
As of April 02, 2026, the company has 4,618 employees.
In which sector is YiChang HEC ChangJiang Pharmaceutical located?▼
YiChang HEC ChangJiang Pharmaceutical operates in the Health Care sector.
When did YiChang HEC ChangJiang Pharmaceutical complete a stock split?▼
The last stock split for YiChang HEC ChangJiang Pharmaceutical was on June 09, 2020 with a ratio of 2:1.
Where is YiChang HEC ChangJiang Pharmaceutical headquartered?▼
YiChang HEC ChangJiang Pharmaceutical is headquartered in Yichang, US.